Full 2L QBank
Pharmacology FMGE 2019 9bc1741f

Mechanism of action of exenatide in diabetes mellitus is

A
It is analogue of GLP released from gut and increase glucose dependant insulin secretion
B
It is DPP-4 inhibitor and result in decreased breakdown of GLP
C
It inhibits SGLT-2 and cause glucosuria
D
It is amylin analogue and decrease glucagon
High-Yield Explanation
Exenatide is a Glucagon like peptide analogue which is approved as an injectable, adjunctive therapy in persons with type 2 DM Saxagliptin -> DPP4 inhibitor which inhibit the metabolism of GLP-1, therefore increase insulin. Canagliflozin, Dapagliflozin, Empagliflozin, Eugliflozin etc. Drugs-inhibit SGLT-2 -Inhibit glucose reabsorption, -result in glucosuria Pramlintide - amylin analogue - Given subcutaneously
← Previous Question Next Question →

Related Pharmacology MCQs

Which of the following is glucocoicoid synthesis inhibitor?
General
At a high altitude of 3000 m, a person complains of breathlessness. All of the following can...
General
All of the following drugs act on cell membrane except:
General
A non-competitive inhibitor of an enzyme?
General
Which of the following is a phase I metabolic reaction?
General
Explore All Pharmacology Questions →

Practice 2,00,000+ NEET PG Questions Free

Timed mock tests, mistake queue analytics, audio lectures & zero attempt limits on i❤️Exams.

Start Free Mock Test Now